Ondansetron for the Treatment of Methamphetamine Dependence - 1
Double-Blind, Placebo-Controlled, Dose Response Trial of Ondansetron for the Treatment of Methamphetamine Dependence.
1 other identifier
interventional
154
1 country
6
Brief Summary
The purpose of this study is to assess ondansetron for the treatment of methamphetamine dependence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Jun 2002
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2002
CompletedFirst Submitted
Initial submission to the registry
June 18, 2002
CompletedFirst Posted
Study publicly available on registry
June 18, 2002
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2004
CompletedJanuary 12, 2017
July 1, 2008
June 18, 2002
January 11, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinicial improvement
Interventions
Eligibility Criteria
You may qualify if:
- years of age. Treatment seeking for meth dependence.
You may not qualify if:
- Please contact site director for more details.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Institute on Drug Abuse (NIDA)lead
- University of Texascollaborator
Study Sites (6)
South Bay Treatment Center
Chula Vista, California, 91911, United States
Matrix Institute on Addictions
Costa Mesa, California, 92627, United States
John A. Burns School of Medicine
Honolulu, Hawaii, 96813, United States
Powell Chemical Dependency Center
Des Moines, Iowa, 50316, United States
University of Missouri - Kansas City
Kansas City, Missouri, 64108, United States
University of Texas Health Science Center
Houston, Texas, 77225, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Newton, M.D.
National Institute on Drug Abuse (NIDA)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Sponsor Type
- NIH
Study Record Dates
First Submitted
June 18, 2002
First Posted
June 18, 2002
Study Start
June 1, 2002
Study Completion
February 1, 2004
Last Updated
January 12, 2017
Record last verified: 2008-07